Neovasc Financial Statements From 2010 to 2024
| NVCNDelisted Stock | USD 30.03 0.00 0.00% |
Check Neovasc financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Neovasc main balance sheet or income statement drivers, such as , as well as many exotic indicators such as . Neovasc financial statements analysis is a perfect complement when working with Neovasc Valuation or Volatility modules.
Neovasc |
Neovasc Company Return On Equity Analysis
Neovasc's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Neovasc Return On Equity | -0.78 |
Most of Neovasc's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Neovasc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
CompetitionBased on the latest financial disclosure, Neovasc has a Return On Equity of -0.7825. This is 96.74% lower than that of the Health Care Equipment & Supplies sector and 91.04% lower than that of the Health Care industry. The return on equity for all United States stocks is 152.42% higher than that of the company.
Neovasc Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Neovasc's current stock value. Our valuation model uses many indicators to compare Neovasc value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Neovasc competition to find correlations between indicators driving Neovasc's intrinsic value. More Info.Neovasc is rated below average in return on equity category among related companies. It is rated below average in return on asset category among related companies . Comparative valuation analysis is a catch-all model that can be used if you cannot value Neovasc by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Neovasc's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Neovasc's earnings, one of the primary drivers of an investment's value.About Neovasc Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Neovasc income statement, its balance sheet, and the statement of cash flows. Neovasc investors use historical funamental indicators, such as Neovasc's revenue or net income, to determine how well the company is positioned to perform in the future. Although Neovasc investors may use each financial statement separately, they are all related. The changes in Neovasc's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Neovasc's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Neovasc Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Neovasc. Please read more on our technical analysis and fundamental analysis pages.
Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada. Neovasc operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 49 people.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. Note that the Neovasc information on this page should be used as a complementary analysis to other Neovasc's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Other Consideration for investing in Neovasc Stock
If you are still planning to invest in Neovasc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Neovasc's history and understand the potential risks before investing.
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |